查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493372

美国血液透析机人造血管市场规模、份额、趋势分析报告：按原料、地区、细分市场预测，2024-2030年

U.S. Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polytetrafluoroethylene), By Region (West, Midwest), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

美国血液透析机血管移植市场的成长与趋势

Grand View Research最近的报告显示，到2030年，美国血液透析机血管移植市场规模预计将达到6,850万美元，2024年至2030年复合年增长率为4.5%。

市场的主要驱动力之一是末期肾病（ESRD）盛行率的上升。 ESRD 是一个重大的公共卫生问题，需要血液透析机作为维持生命治疗的患者数量不断增加。患者数量的增加推动了对血液透析机移植物的需求，以确保可靠地进行透析程序。

在血液透析机血管通路领域，微创手术有明显的趋势。微创技术可减少与传统手术介入相关的患者不适、恢復时间和併发症。因此，医疗保健提供者越来越多地采用支持微创方法的血液透析机移植物，推动市场成长。

2023 年 4 月，BD 引入了采用 6F 和 8F 导管的 Aspirex 机械抽吸血栓切除系统，用于清除急性栓塞和血栓，以便血液透析机进入动静脉移植物和自体动静脉瘻管（Becton Dickinson & Company）。作为510(k) 使用。该设备将于 2022 年推出，具有三大支柱：透过导管有效清除通道中的凝块的机械输送、防止堵塞的连续凝块浸渍以及增强的凝块抽吸功能。

美国血液透析机人工血管市场报告亮点

  • 随着人口老化以及糖尿病、高血压等疾病的增加，需要血液透析机的人数不断增加，推动了人造血管市场的发展。
  • 预计到 2023 年，聚四氟乙烯原料领域将以 45.5% 左右的份额主导市场，并在预测期内呈现最快的复合年增长率。这是由于它具有易于物料输送、耐用性和抗感染性等优点。
  • 2023年6月，Merit Medical System Inc.以3,250万美元收购了Bluegrass Vascular的导管系统，随后又收购了AngioDynamics超过1亿美元的资产。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国血液透析机人工血管市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国血液透析机人工血管市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国血液透析机人工血管市场：依原料估算及趋势分析

  • 原物料市场占有率（2023/2030）
  • 细分仪表板
  • 美国血液透析机人造血管市场前景：依原料分
  • 市场规模、预测与趋势分析（2018-2030）

第五章美国血液透析机人工血管市场：区域估计与趋势分析

  • 市场占有率分析：按地区（2023/2030）
  • 美国血液透析机人工血管市场前景：按地区
  • 市场规模、预测与趋势分析（2018-2030）
    • 西
    • 中西部
    • 东北
    • 西南
    • 东南

第六章 竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 主要企业热图分析（2023）
  • 公司简介
    • Getinge
    • Medtronic
    • WL Gore &Associates
    • LeMaitre
    • CryoLife
    • Merit Medical Systems
    • CR Bard, Inc.
    • Vascudyne, Inc.
Product Code: GVR-4-68040-286-1

U.S. Hemodialysis Vascular Grafts Market Growth & Trends:

The U.S. hemodialysis vascular grafts market size is anticipated to reach USD 68.5 million by 2030, growing at a CAGR of 4.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the primary drivers of the market is the rising prevalence of end-stage renal disease (ESRD). ESRD is a significant public health concern, with a growing number of patients requiring hemodialysis as a life-sustaining treatment. This increasing patient population drives the demand for hemodialysis vascular grafts to create reliable access to dialysis procedures.

There is a noticeable trend towards minimally invasive procedures in the field of vascular access for hemodialysis. Minimally invasive techniques reduce patient discomfort, recovery time, and complications associated with traditional surgical interventions. As a result, healthcare providers are increasingly adopting hemodialysis vascular grafts that support minimally invasive approaches, driving market growth.

In April 2023, the Aspirex mechanical suction thrombectomy system, which employs 6- and 8-F catheters, was approved by the FDA under 510(k) for use by BD (Becton, Dickinson, and Company) to remove acute emboli and clots for hemodialysis access to arteriovenous grafts and native arteriovenous fistulas. This device was introduced in 2022 and operates on a three-pronged mechanism mechanical transportation for effective clot removal through the catheter and out of the channel, continuous clot maceration to prevent clogging, and enhanced clot aspiration.

U.S. Hemodialysis Vascular Grafts Market Report Highlights:

  • As the population ages and the prevalence of conditions such as diabetes and hypertension increases, more individuals require hemodialysis, driving the market for vascular grafts.
  • The polytetrafluoroethylene raw material segment dominated the market with a share of around 45.5% in 2023 and is anticipated to witness the fastest CAGR during the forecast period. This is attributed to the benefits associated with the material such as ease of handling, durability, and resistance to infection.
  • In June 2023, Merit Medical System Inc. acquired a catheter system from Bluegrass Vascular for USD 32.5 million followed with a larger USD 100 million asset purchase from AngioDynamics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Raw Material
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Raw material outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Hemodialysis Vascular Grafts Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. U.S. Hemodialysis Vascular Grafts Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Hemodialysis Vascular Grafts Market: Raw Material Estimates & Trend Analysis

  • 4.1. Raw Material Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Hemodialysis Vascular Grafts Market by Raw Material Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Polyester
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Polytetrafluoroethylene
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Polyurethane
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Biological Materials
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.4.2. Human Saphenous & Umbilical Veins
      • 4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.4.3. Tissue Engineered Materials
      • 4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Hemodialysis Vascular Grafts Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. U.S. Hemodialysis Vascular Grafts Market by Region Outlook
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
    • 5.3.1. West
      • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Midwest
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Northeast
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Southwest
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Southeast
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company heat map analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. Getinge
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Medtronic
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. W. L. Gore & Associates
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. LeMaitre
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. CryoLife
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Merit Medical Systems
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. C.R. Bard, Inc.
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Vascudyne, Inc.
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. hemodialysis vascular grafts market, by raw material, 2018 - 2030 (USD Million)
  • Table 3 U.S. hemodialysis vascular grafts market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. hemodialysis vascular grafts market: Market outlook
  • Fig. 9 U.S. hemodialysis vascular grafts competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. hemodialysis vascular grafts market driver impact
  • Fig. 14 U.S. hemodialysis vascular grafts market restraint impact
  • Fig. 15 U.S. hemodialysis vascular grafts market: Raw material movement analysis
  • Fig. 16 U.S. hemodialysis vascular grafts market: Raw material outlook and key takeaways
  • Fig. 17 Polyester market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Polytetrafluoroethylene market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Polyurethane market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Biological materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Human saphenous & umbilical veins market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 22 Tissue engineered materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. hemodialysis vascular grafts market: Regional movement analysis
  • Fig. 24 U.S. hemodialysis vascular grafts market: Regional outlook and key takeaways
  • Fig. 25 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)